Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText.
Kick-your-searchterm to multiple Engines kick-your-query now !>
A dictionary by aggregated review articles of nephrology, medicine and the life sciences
Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

suck abstract from ncbi


10.1002/jmv.26911

http://scihub22266oqcxt.onion/10.1002/jmv.26911
suck pdf from google scholar
33638460!8014076!33638460
unlimited free pdf from europmc33638460    free
PDF from PMC    free
html from PMC    free

suck abstract from ncbi


Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534
pmid33638460      J+Med+Virol 2021 ; 93 (7): 4205-4218
Nephropedia Template TP

gab.com Text

Twit Text FOAVip

Twit Text #

English Wikipedia


  • Spiking dependence of SARS-CoV-2 pathogenicity on TMPRSS2 #MMPMID33638460
  • Abbasi AZ; Kiyani DA; Hamid SM; Saalim M; Fahim A; Jalal N
  • J Med Virol 2021[Jul]; 93 (7): 4205-4218 PMID33638460show ga
  • Epidemiological data shows a discrepancy in COVID-19 susceptibility and outcomes with some regions being more heavily affected than others. However, the factors that determine host susceptibility and pathogenicity remain elusive. An increasing number of publications highlight the role of Transmembrane Serine Protease 2 (TMPRSS2) in the susceptibility of the host cell to SARS-CoV-2. Cleavage of viral spike protein via the host cell's TMPRSS2 enzyme activity mediates viral entry into the host cell. The enzyme synthesis is regulated by the TMPRSS2 gene, which has also been implicated in the entry mechanisms of previously reported Coronavirus infections. In this review, we have investigated the pathogenicity of SARS-CoV-2 and disease susceptibility dependence on the TMPRSS2 gene as expressed in various population groups. We further discuss how the differential expression of this gene in various ethnic groups can affect the SARS-CoV-2 infection and Coronavirus disease (COVID)-19 outcomes. Moreover, promising new TMPRSS2 protease blockers and inhibitors are discussed for COVID-19 treatment.
  • |*COVID-19 Drug Treatment[MESH]
  • |Anosmia/pathology[MESH]
  • |COVID-19/pathology[MESH]
  • |Female[MESH]
  • |Genetic Predisposition to Disease/genetics[MESH]
  • |Humans[MESH]
  • |Male[MESH]
  • |SARS-CoV-2/drug effects[MESH]
  • |Serine Endopeptidases/*drug effects/genetics/*metabolism[MESH]
  • |Spike Glycoprotein, Coronavirus/metabolism[MESH]


  • DeepDyve
  • Pubget Overpricing
  • suck abstract from ncbi

    Linkout box